Xiao_2014_Chin.Chem.Lett_25_673

Reference

Title : Discovery of dipeptidyl peptidase IV (DPP4) inhibitors based on a novel indole scaffold - Xiao_2014_Chin.Chem.Lett_25_673
Author(s) : Xiao P , Guo R , Huang S , Cui H , Ye S , Zhang Z
Ref : Chin Chem Lett , 25 :673 , 2014
Abstract :

Dipeptidyl peptidase IV (DPP4) inhibitors are proven in the treatment of type 2 diabetes. We designed and synthesized a series of novel indole compounds that selectively inhibit the activity of DPP4 over dipeptidyl peptidase 9 (DPP9) (>200 fold). We further co-crystallized DPP4 with indole sulfonamide (compound 1) to confirm a proposed binding mode. Good metabolic stability of the indole compounds represents another positive attribute for further development.

PubMedSearch : Xiao_2014_Chin.Chem.Lett_25_673
PubMedID:
Gene_locus related to this paper: human-DPP4

Related information

Inhibitor Indolesufonamide1
Gene_locus human-DPP4
Structure 4PV7

Citations formats

Xiao P, Guo R, Huang S, Cui H, Ye S, Zhang Z (2014)
Discovery of dipeptidyl peptidase IV (DPP4) inhibitors based on a novel indole scaffold
Chin Chem Lett 25 :673

Xiao P, Guo R, Huang S, Cui H, Ye S, Zhang Z (2014)
Chin Chem Lett 25 :673